Treatment of vitiligo with the topical Janus kinase inhibitor ruxolitinib: A 32-week open-label extension study with optional narrow-band ultraviolet B.
作者信息
Joshipura Deep, Alomran Abdulaziz, Zancanaro Pedro, Rosmarin David
机构信息
Department of Dermatology, Tufts Medical Center, Boston, Massachusetts.
Department of Dermatology, Tufts Medical Center, Boston, Massachusetts.
出版信息
J Am Acad Dermatol. 2018 Jun;78(6):1205-1207.e1. doi: 10.1016/j.jaad.2018.02.023. Epub 2018 Feb 10.
PMID:29438765
Abstract
摘要
Zotero 插件